Factors associated with dyspnea in adult patients with sickle cell disease.
OBJECTIVE
The aim of this prospective study was to determine the cardiorespiratory factors associated with dyspnea in patients with sickle cell SS-hemoglobin disease, with a specific interest in lung vascular involvement.


METHODS
Forty-nine patients (29 women and 20 men; mean [+/- SD] age: women, 29 +/- 6 years; men, 31 +/- 11 years) underwent direct evaluations (Borg scale evaluation during a 6-min walk test) and indirect evaluations (modified Medical Research Council [MRC]score) of their dyspnea, pulmonary function tests (PFTs) [spirometry, volumes, diffusing capacity of the lung for carbon monoxide (Dlco), diffusing capacity of the alveolar-capillary membrane, and pulmonary capillary blood volume measurements], echocardiography, and biological evaluation.


RESULTS
Thirty-four patients complained of significant breathlessness (MRC score, > 1). Indirect and direct evaluations of dyspnea were correlated. PFT results depicted a very mild restrictive pattern (mean total pulmonary capacity, 86 +/- 11% predicted) and an impairment of Dlco (mean Dlco corrected for the degree of anemia, 69 +/- 13% predicted). The statistical analysis demonstrated that dyspnea and exercise performance were closely linked to indexes of Dlco but not with any echocardiographic or biological measure including anemia. Nevertheless, only approximately 25% of the variability was explained by these associations. Despite having a similar history of vasoocclusive crisis events, women had more severe anemia, dyspnea, decreases in Dlco (corrected for the degree of anemia), and a higher capillary blood volume (corrected for alveolar volume) than men.


CONCLUSIONS
Lung vascular disease contributes to dyspnea and the exercise limitation of patients with sickle cell disease. A sequential assessment of Dlco would therefore constitute one of the objective functional end points for follow-up studies of these patients.
Delclaux
Christophe
C
Service de Physiologie, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France. christophe.delclaux@egp.aphp.fr
Zerah-Lancner
Françoise
F
Bachir
Dora
D
Habibi
Anoosha
A
Monin
Jean-Luc
JL
Godeau
Bertrand
B
Galacteros
Frédéric
F
D000328:Adult; D000755:Anemia, Sickle Cell / Q000453:epidemiology* / Q000503:physiopathology; D001944:Breath Tests; D004417:Dyspnea / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000453:epidemiology* / Q000503:physiopathology; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism; D011446:Prospective Studies; D011650:Pulmonary Alveoli / Q000378:metabolism; D011653:Pulmonary Diffusing Capacity; D012129:Respiratory Function Tests
D009569:Nitric Oxide